Erythropoietin and hepatocellular carcinoma: What is patients survival outcome?

Abdel-Wahab R., Hassan M., Lacin S., Shalaby A. S., Afshar-Kharghan V., Kaseb A. O.

53rd Annual Clinical Science Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Symposium on Old Targets, New Drugs - Her2 and MET, Illinois, United States Of America, 2 - 07 June 2017, vol.35, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 35
  • Doi Number: 10.1200/jco.2017.35.15_suppl.e15660
  • City: Illinois
  • Country: United States Of America
  • Hacettepe University Affiliated: Yes